These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19320193)

  • 1. Comparative analysis of methods for accurate recognition of cells through nuclei staining of Ki-67 in neuroblastoma and estrogen/progesterone status staining in breast cancer.
    Markiewicz T; Wisniewski P; Osowski S; Patera J; Kozlowski W; Koktysz R
    Anal Quant Cytol Histol; 2009 Feb; 31(1):49-62. PubMed ID: 19320193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.
    Tuominen VJ; Ruotoistenmäki S; Viitanen A; Jumppanen M; Isola J
    Breast Cancer Res; 2010; 12(4):R56. PubMed ID: 20663194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast unsupervised nuclear segmentation and classification scheme for automatic allred cancer scoring in immunohistochemical breast tissue images.
    Mouelhi A; Rmili H; Ali JB; Sayadi M; Doghri R; Mrad K
    Comput Methods Programs Biomed; 2018 Oct; 165():37-51. PubMed ID: 30337080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
    Pu T; Shui R; Shi J; Liang Z; Yang W; Bu H; Li Q; Zhang Z;
    BMC Cancer; 2019 Oct; 19(1):978. PubMed ID: 31640622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics.
    Abele N; Tiemann K; Krech T; Wellmann A; Schaaf C; Länger F; Peters A; Donner A; Keil F; Daifalla K; Mackens M; Mamilos A; Minin E; Krümmelbein M; Krause L; Stark M; Zapf A; Päpper M; Hartmann A; Lang T
    Mod Pathol; 2023 Mar; 36(3):100033. PubMed ID: 36931740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.
    Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
    J BUON; 2013; 18(1):57-63. PubMed ID: 23613389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reliability of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 expression in breast cancer evaluated by immunohistochemistry].
    Gu CS; Ying M; He YJ; Liu YQ; Dong B; Ouyang T; Lu AP
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(32):2571-3. PubMed ID: 24351599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer.
    Sharangpani GM; Joshi AS; Porter K; Deshpande AS; Keyhani S; Naik GA; Gholap AS; Barsky SH
    J Microsc; 2007 Jun; 226(Pt 3):244-55. PubMed ID: 17535263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multisite performance study comparing the reading of immunohistochemical slides on a computer monitor with conventional manual microscopy for estrogen and progesterone receptor analysis.
    Nassar A; Cohen C; Agersborg SS; Zhou W; Lynch KA; Barker EA; Vanderbilt BL; Thompson J; Heyman ER; Olson A; Lange H; Siddiqui MT
    Am J Clin Pathol; 2011 Mar; 135(3):461-7. PubMed ID: 21350103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tamoxifen on expression of ER, PR, Cerb-B2, and ki-67 in C3H mice spontaneous breast cancer model and the relation with chemotherapeutic effect.
    Li X; Zhang S; Liu W; Li H
    Cell Biochem Biophys; 2014 Dec; 70(3):1875-9. PubMed ID: 25168102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.
    Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
    J BUON; 2013; 18(2):366-71. PubMed ID: 23818347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
    Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
    Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.
    Gertych A; Mohan S; Maclary S; Mohanty S; Wawrowsky K; Mirocha J; Balzer B; Knudsen BS
    Diagn Pathol; 2014 Nov; 9():213. PubMed ID: 25421113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of nodal metastasis and prognosis of breast cancer by ANN-based assessment of tumour size and p53, Ki-67 and steroid receptor expression.
    Mojarad S; Venturini B; Fulgenzi P; Papaleo R; Brisigotti M; Monti F; Canuti D; Ravaioli A; Woo L; Dlay S; Sherbet GV
    Anticancer Res; 2013 Sep; 33(9):3925-33. PubMed ID: 24023330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin-Supervised Deep Learning for Automatic Recognition of Epithelial Cells in Breast Cancers Stained for ER, PR, and Ki-67.
    Valkonen M; Isola J; Ylinen O; Muhonen V; Saxlin A; Tolonen T; Nykter M; Ruusuvuori P
    IEEE Trans Med Imaging; 2020 Feb; 39(2):534-542. PubMed ID: 31398111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast.
    Gill MS; Paish EC; Ronan J; Green AR; Ellis IO; Lee AH
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):90-3. PubMed ID: 22820666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology.
    Paulik R; Micsik T; Kiszler G; Kaszál P; Székely J; Paulik N; Várhalmi E; Prémusz V; Krenács T; Molnár B
    Cytometry A; 2017 Jun; 91(6):595-608. PubMed ID: 28472544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
    Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
    Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
    Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Ulas A; Hartavi M; Kurt E; Evrensel T
    J BUON; 2015; 20(1):45-9. PubMed ID: 25778295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.